COVID-19 Ag FIA is an antigen-based rapid immunofluorescence assay for qualitative detection of SARS-CoV-2 in respiratory specimens. This in vitro diagnostic test provides results to aid in clinical diagnosis of COVID-19 infection and supports patient management and infection control protocols.
Manufactured by
Suwon-si, South Korea
SD BIOSENSOR is an in-vitro diagnostics company that contributes to improving the quality of life by quickly and accurately diagnosing diseases under the slogan Beginning of all things that protect lives . We have provided various diagnostic platforms to the IVD industry through the constant technological innovation such as POC Molecular Diagnostics, Fluorescent Immunoassay, Immunochromatography, BGMS and CGMS. The headquarters of SD BIOSENSOR is located in Korea and, the subsidiaries are placed in the Brazil, Panama, Colombia, India, Indonesia, Germany, Italy and Spain.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
GenBody Inc.
South Korea · 5 relevant products
SJK Global LLC
United States · 1 relevant product
Xiamen Biotime Biotechnology Co., Ltd.
China · 5 relevant products
Qingdao Hightop Biotech Co., Ltd
China · 3 relevant products
Shenzhen Microprofit Biotech Co., Ltd
China · 2 relevant products
Shenzhen Diasia Biomedical Technology Co.,Ltd
China · 1 relevant product
Jiangsu Medomics Medical Technology Co.,Ltd.
China · 7 relevant products
Hangzhou Frenovo Biotech Co., Ltd
China · 3 relevant products
Neo-nostics (Suzhou) Bioengineering Co., Ltd
China · 1 relevant product
ProGnosis Biotech S.A.
Greece · 3 relevant products
64 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →5 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 113 closest product alternatives
GenBody Inc. · South Korea
Rapid antigen test for qualitative detection of SARS-CoV-2 in respiratory specimens. The fluorescent immunochromatographic assay enables quick COVID-19 diagnosis with high sensitivity and specificity, suitable for point-of-care and laboratory settings.
GenBody Inc. · South Korea
Fluorescence immunoassay system for rapid detection of influenza A and B antigens. Provides quick molecular confirmation of influenza infection in clinical settings.
SJK Global LLC · United States
Fluorescence-based immunoassay technology for point-of-care applications using the LTRIC-600 benchtop analyzer. FIA provides rapid results with sensitive detection capabilities.
Xiamen Biotime Biotechnology Co., Ltd. · China
Fluorescence immunoassay test for infectious disease markers. Detects pathogens and disease-specific antibodies for infectious disease diagnosis.
Qingdao Hightop Biotech Co., Ltd · China
A fluorescence immunoassay diagnostic solution for rapid detection and identification of pathogens.
Shenzhen Microprofit Biotech Co., Ltd · China
CE-marked fluorescence immunoassay (FIA) analyzer for quantitative point-of-care testing. The MF-T1000 platform delivers rapid diagnostic results with 92.9%+ sensitivity, supporting respiratory combo tests (4-in-1/9-in-1 configurations) for clinical laboratories and healthcare facilities.
Xiamen Biotime Biotechnology Co., Ltd. · China
Fluorescence immunoassay test for autoimmune disease markers. Supports diagnosis of autoimmune conditions through antibody and antigen detection.
GenBody Inc. · South Korea
Rapid or lab-based test for detection of Influenza A and B viral antigens. Available in RDT and FIA formats for point-of-care and laboratory settings.
Shenzhen Diasia Biomedical Technology Co.,Ltd · China
A high-precision analyzer utilizing fluorescence immunoassay (FIA) technology for rapid immunological testing and diagnosis. The system is designed for clinical chemistry and immunofluorescence applications in point-of-care testing.
Jiangsu Medomics Medical Technology Co.,Ltd. · China
Rapid lateral flow immunoassay for qualitative detection of SARS-CoV-2 antigens. Enables quick point-of-care testing for COVID-19 diagnosis.
Hangzhou Frenovo Biotech Co., Ltd · China
A rapid antigen test kit for detecting SARS-CoV-2 in COVID-19 diagnosis. This test provides quick results for preliminary screening and emergency medical situations.
Jiangsu Medomics Medical Technology Co.,Ltd. · China
Multiplex lateral flow assay for simultaneous detection of COVID-19 and influenza A and B antigens. Allows differentiation of respiratory pathogens in a single test.
101 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products